Brief: CMS Announces Manufacturer Participation in Second Cycle of Medicare Drug Price Negotiation
14/03/2025 21:56
March 14 (Reuters) - CMS: DEALS SIGNED WITH MANUFACTURERS OF 15 DRUGS COVERED UNDER MEDICARE PART D SELECTED FOR SECOND CYCLE OF MEDICARE DRUG PRICE NEGOTIATION PROGRAM ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Astellas Pharma
See all newsFocus: Trump's push for the world's lowest drug prices hits snag with mid-sized companies
China detains two Japanese nationals suspected of smuggling banned goods (updated)
Brief: Astellas Pharma: Institutional Shareholder Services Has Issued A Report Recommending A Vote Against A Director Candidate
Health Rounds: Veracyte genomic test identifies breast cancer patients who can skip chemo
Advisory: Alert wrongly tagged to Gold Rain Enterprises withdrawn